Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000375853 | SCV000329989 | pathogenic | not provided | 2022-01-13 | criteria provided, single submitter | clinical testing | Not observed at significant frequency in large population cohorts (gnomAD); Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; This variant is associated with the following publications: (PMID: 25525159, 23553736, 22088788, 28464723, 25557462, 18180250) |
Genomic Research Center, |
RCV000626064 | SCV000746686 | pathogenic | Congenital myasthenic syndrome 5 | 2017-12-18 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000375853 | SCV001246037 | pathogenic | not provided | 2019-04-01 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000626064 | SCV003525314 | pathogenic | Congenital myasthenic syndrome 5 | 2022-09-01 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 280125). This premature translational stop signal has been observed in individual(s) with congenital myasthenic syndrome (PMID: 18180250, 22088788, 23553736, 25557462). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. This variant is present in population databases (rs770045897, gnomAD 0.0009%). This sequence change creates a premature translational stop signal (p.Arg227*) in the COLQ gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in COLQ are known to be pathogenic (PMID: 22678886). |
Neuromuscular Department, |
RCV003321579 | SCV004027606 | pathogenic | Synaptic congenital myasthenic syndromes | 2023-01-01 | criteria provided, single submitter | clinical testing | |
Baylor Genetics | RCV000626064 | SCV004214444 | pathogenic | Congenital myasthenic syndrome 5 | 2024-03-20 | criteria provided, single submitter | clinical testing |